DSM and Diversa Corporation sign an agreement to develop biocatalysts for making pharmaceutical intermediates

• Publisher: Elsevier Science
• Year: 2004
• Weight: 64 KB
• Volume: 2004
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(04)00286-7

✦ Synopsis

BASF licenses proprietary enzyme

Diversa Corp has granted BASF a licence to a proprietary enzyme for the biocatalytic synthesis of a pharmaceutical intermediate. BASF will manufacture the biocatalyst and use it in one of its processes to synthesise a chiral intermediate. Manufacturing Chemist, Mar 2004, 75 (3), 18 Polyolefin catalyst supply agreement BP Petrochemicals and Nova Chemicals have entered into a longterm supply agreement with the polyolefin catalyst business of Grace Davison. It will produce Novacat T advanced Ziegler-Natta catalysts, which are available to worldwide customers via Nova Chemicals and BP's Innovene licensing business. The catalysts are for use in gas-phase PE plants.